Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
52,223,325
-
Total 13F shares
-
3,840,738
-
Share change
-
-243,610
-
Total reported value
-
$10,907,609
-
Put/Call ratio
-
78%
-
Price per share
-
$2.84
-
Number of holders
-
37
-
Value change
-
-$629,214
-
Number of buys
-
16
-
Number of sells
-
6
Institutional Holders of DiaMedica Therapeutics Inc. - Common Shares, no par value (DMAC) as of Q4 2023
As of 31 Dec 2023,
DiaMedica Therapeutics Inc. - Common Shares, no par value (DMAC) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,840,738 shares.
The largest 10 holders included
COOPERMAN LEON G, VANGUARD GROUP INC, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, Altium Capital Management LP, Bleichroeder LP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, MORGAN STANLEY, FIRST MANHATTAN CO. LLC., and Aristides Capital LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.